· Issued by Morepen Laboratories Limited via NSE India
Filed with NSE · · 4 pages · English
Summary by 6ix AI
Morepen Laboratories Limited has released a press statement detailing its strong performance for the fourth quarter, highlighting a significant increase in net profit and revenue compared to the previous year. The company reported a rise in net profit and gross revenue, driven by growth in its export activities and medical devices sector. Additionally, the board has proposed a dividend for shareholders for the fiscal year, reflecting the company's positive financial results.
Morepen Laboratories Limited has informed the Exchange regarding a press release dated May 27, 2026, titled "Morepen Labs Q4 Net Profit Rises 69%; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10% to the shareholders for FY26.".